A cancer specialist has delved into the key red flags of malignant moles - and a common myth of what's normal. Dr James Wilson, a London-based oncologist, was invited on the Dr Hilary Show at a time ...

A cancer specialist has delved into the key red flags of malignant moles - and a common myth of what's normal.

During a live event, Barbara T. Ma, MD, MS, reviewed guidelines on management and best practices for the use of tumor-infiltrating lymphocytes in melanoma.

Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.

Skin Cancer is the most common form of cancer, and occurs when malignant (cancerous) cells form in the skin's tissues. The ...

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The ...

A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.

Line or Earlier Patients SAN CARLOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and ...

Tracking growth in high-risk choroidal nevi revealed key genetic shifts and low metastatic risk, supporting timely ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Recent ASCO 2025 findings reveal new insights into melanoma treatment, highlighting challenges and advancements in adjuvant ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...